Involvement of leptin in the association between percentage of body fat and cardiovascular risk factors

Clinical Biochemistry

Volumn 35, Issue 4, 2002, Pages 315-320

  Gómez Ambrosi, Javier ^a   Salvador, Javier ^a   Páramo, Jose A ^b   Orbe, Josune ^b   De Irala, Jokin ^b   Diez Caballero, Alberto ^a   Gil, María J ^a   Cienfuegos, Javier A ^a   Frühbeck, Gema ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Cardiovascular risk; Fibrinogen; Insulin sensitivity; Leptin; Obesity

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INSULIN; PROTHROMBIN; VON WILLEBRAND FACTOR; CHOLESTEROL; DRUG DERIVATIVE; GLUCOSE; LEPTIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD ANALYSIS; BODY FAT; BODY PLETHYSMOGRAPHY; CALCULATION; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM LESION; FIBRINOGEN BLOOD LEVEL; HUMAN; INSULIN SENSITIVITY; MALE; OBESITY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; ADIPOSE TISSUE; AGED; BLOOD; BODY COMPOSITION; BODY MASS; CARDIOVASCULAR DISEASE; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADIPOSE TISSUE; ADULT; AGED; BODY COMPOSITION; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL; FIBRINOGEN; GLUCOSE; HOMOCYSTEINE; HUMAN; INSULIN RESISTANCE; LEPTIN; MALE; MIDDLE AGE; OBESITY; RISK FACTORS; TRIGLYCERIDES; VON WILLEBRAND FACTOR; HUMANS; MIDDLE AGED;

EID: 0035992631     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(02)00320-X     Document Type: Article

References (48)

1. The continuing epidemics of obesity and diabetes in the United States
2. The nutrition transition and obesity in the developing world
3. Overweight, obesity, and health risk
4. The adipocyte: A model for integration of endocrine and metabolic signaling in energy metabolism regulation
5. A heliocentric view of leptin
6. Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort
7. Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women
8. High plasma immunoreactive leptin level in essential hypertension
9. Leptin enhances the calcification of vascular cells: Artery wall as a target of leptin
10. Hyperleptinaemia in chronic heart failure. Relationships with insulin
11. Independent association between plasma leptin levels and heart rate in heart transplant recipients
12. Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk
13. Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS)
14. Comparison of air displacement plethysmography with dual-energy X-ray absorptiometry and 3 field methods for estimating body composition in middle-aged men
15. New techniques in nutritional assessment: Body composition methods
16. Precision of measurement and body size in whole-body air-displacement plethysmography
17. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen
18. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without the use of preparative ultra-centrifuge
19. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
20. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans
21. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study
22. A prospective study of obesity and risk of coronary heart disease in women
23. Association between obesity and coronary atherosclerosis and vascular remodeling
24. American Heart Association call to action: Obesity as a major risk factor for coronary heart disease
25. Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men
26. Increase in both pro-thrombotic and anti-thrombotic factors in obese premenopausal women: Relationship with body fat distribution
27. Von Willebrand factor, the endothelium, and obesity
28. Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men
29. The relation of body fat mass and distribution to markers of chronic inflammation
30. Raised interleukin-6 levels in obese patients
31. Transcriptional control mechanism of fibrinogen gene expression
32. High-sensitivity C-reactive protein, and atherosclerosis: From theory to therapy
33. Leptin regulates proinflammatory immune responses
34. Effect of ciprofibrate on fibrinogen synthesis in vitro on hepatoma cells and in vivo in genetically obese Zucker rats
35. Elevated C-reactive protein levels in overweight, and obese adults
36. Elevated C-reactive protein: Another component of the atherothrombotic profile of abdominal obesity
37. Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects
38. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS)
39. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians
40. Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals
41. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue?
42. Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease
43. Von Willebrand factor and soluble E-selectin in hyperlipidaemia: Relationship to lipids and vascular disease
44. Plasma homocysteine concentrations in type II diabetic patients in India: Relationship to body weight
45. Effect of obesity on plasma homocysteine: Author reply
46. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort
47. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: The Framingham Offspring Study